BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 1998
View Archived Issues
Disappointing results of pilot study of SDZ-PSC-833 + doxorubicin in colorectal cancer
Read More
More data reported for ADCON-P; FDA okays pivotal trial
Read More
Aphton initiates phase I/II trial of Gonadimmune in prostate cancer patients
Read More
Hybridon advances antisense drug to phase II
Read More
Another market introduction for Novartis bisphosphonate
Read More
Introgen acquires option to license Bak gene from LXR
Read More
Cortecs: year-end 1998 highlights
Read More
COHERE will track long-term effects of beta-blockade in heart failure
Read More
Nobel award brings nitric oxide into the limelight
Read More
Novel series of inhibitors of protein farnesyltransferase developed at RPR
Read More
New heteroarylsulfonamide derivatives from Knoll with broad clinical application
Read More
Stroke patients benefit from treatment with anti-ICAM-1 MAb
Read More
Bicyclic inhibitors of protein farnesyltransferase for cancer, restenosis, etc.
Read More
Roche presents series of OFQ (ORL1) receptor agonists/antagonists
Read More
Immunomodulating thalidomide analogues patented by Gruenenthal
Read More
Genset, Pharmacia & Upjohn collaborate in pharmacogenomics research
Read More
Abbott will collaborate with Nippon Shinyaku on development of incontinence Rx
Read More
U.S. patent covers protegrins and synthetic analogues such as IntraBiotics' IB-367
Read More
Fluoroquinolone derivative K-12 inhibits HIV in vitro
Read More
Demegen receives patent protection for Peptidyl MIMs in cancer indications
Read More
Antibody-based cancer product from AltaRex heading for phase I testing
Read More
Access signs more agreements for distribution of amlexanox
Read More
Successful completion of human safety trials reported for VIMRx wound-healing agent
Read More
AHP and Monsanto agree not to merge
Read More
Asahi expects approval of dysuria Rx in near future
Read More
CEA-Cide receives orphan drug designation
Read More
Treatment recommendations for generalized convulsive status epilepticus emerge from VA study
Read More
Rituximab now available in Germany
Read More
